quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, R Supply Disruption — Pfizer Inc. (Moderate Risk —
quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, R Supply Disruption — Pfizer Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, R; Manufacturer: Pfizer
| Drug name | quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, R |
|---|---|
| Manufacturer | Pfizer Inc. |
| Recall/Disruption reason | CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0759-2022 |
| Initiation date | 20220321 |
| Quantity affected | 21108 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →